Skip to content
value.today

Enable Injections, LLC

🇺🇸 Franklin, Ohio, USAHealth CareFounded 2010
Total raised
$245 M
7 rounds on record
Latest round
$30 M
Dec 2025
First round on record
May 2012
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Enable Injections, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2025$30 MNo. 7$10 to $50 million

Enable Injections, LLC: Raise no. 7, Dec 2025

Investors in this round

1 investor had bought by the notice of Jan 9, 2026: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David D. Kroekel · Executive Officer
  • Matt D. Huddleston · Executive Officer
  • Michael D. Hooven · Executive Officer, Director
  • Timothy Flaherty · Executive Officer
  • Beckie J. Robertson · Director
  • Erik D. Falk · Director
  • Jim J. Collins · Director
  • John J. DeFord · Director
  • John J. Rice · Director
  • Nigel J. Sheail · Director
  • Richard J. D'Augustine · Director
  • Simone D. Song · Director
  • Vickie J. Capps · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Timothy Flaherty, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 9, 2026. Read the notice at the SEC.

equitySEC
Jan 2022$150 MNo. 6$50 to $250 million

Enable Injections, LLC: Raise no. 6, Jan 2022

Investors in this round

22 investors had bought by the notice of Feb 3, 2022: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$150 M of $215 M offered; $65 M still to sell
Smallest investment taken
$1
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$8,252,453
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael D. Hooven · Executive Officer, Director
  • Timothy R. Flaherty · Executive Officer
  • John J Rice · Director
  • Karen J Robards · Director
  • Norman R. Weldon · Director
  • Richard J D'Augustine · Director
  • Simone J Song · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • UBS Securities LLC · New York, New YorkSold in CO, IL, NY, OH, TX

Signed by Michael Hooven, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 3, 2022. Read the notice at the SEC.

equity, debtSEC
Oct 2018$31 MNo. 5$10 to $50 million

Enable Injections, LLC: Raise no. 5, Oct 2018

Investors in this round

15 investors had bought by the notice of Oct 30, 2018: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $50 M offered; $19 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael D. Hooven · Executive Officer, Director
  • Susan D. Spies · Executive Officer
  • Timothy D. Flaherty · Executive Officer
  • Daniel D. von Allmen · Director
  • John D. Rice · Director
  • Mark A. Collar · Director
  • Norman D. Weldon · Director
  • Richard D. D'Augustine · Director
  • Simone A. Song · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Timothy Flaherty, Executive Vice President & Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 30, 2018. Read the notice at the SEC.

equitySEC
Aug 2016$25 MNo. 4$10 to $50 million

Enable Injections, LLC: Raise no. 4, Aug 2016

Investors in this round

1 investor had bought by the notice of Nov 17, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Hooven · Executive Officer
  • Susan Spies · Executive Officer
  • Timothy Flaherty · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Hooven, President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 17, 2016. Read the notice at the SEC.

equitySEC
Jun 2016$5 MNo. 3$2 to $10 million

Enable Injections, LLC: Raise no. 3, Jun 2016

Investors in this round

19 investors had bought by the notice of Aug 2, 2016: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Michael Hooven · Executive Officer
  • Susan Spies · Executive Officer
  • Timothy Flaherty · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Hooven, President & CEO. Source: SEC Form D, newest notice filed Aug 2, 2016. Read the notice at the SEC.

equitySEC
Sep 2014$2 MNo. 2$2 to $10 million

Enable Injections, LLC: Raise no. 2, Sep 2014

Investors in this round

13 investors had bought by the notice of Apr 18, 2016: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Michael Hooven · Executive Officer
  • Susan Spies · Executive Officer
  • Timothy Flaherty · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Timothy Flaherty, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 18, 2016. Read the notice at the SEC.

equitySEC
May 2012$2 MNo. 1$2 to $10 million

Enable Injections, LLC: Raise no. 1, May 2012

Investors in this round

13 investors had bought by the notice of Aug 22, 2016: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Michael Hooven · Executive Officer
  • Susan Spies · Executive Officer
  • Timothy Flaherty · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Hooven, President & CEO. Source: SEC Form D, newest notice filed Aug 22, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Enable Injections, LLC chose not to state its revenue in its newest notice of a funding round (Jan 2026).

    SEC Form D · Jan 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2026

That is all the official record says: Enable Injections, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Enable Injections, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Enable Injections, LLC
NameRoleNamed in
David D. KroekelExecutive officerJan 2026
Matt D. HuddlestonExecutive officerJan 2026
Michael D. HoovenExecutive officerJan 2026
Timothy FlahertyExecutive officerJan 2026
Timothy R. FlahertyExecutive officerFeb 2022
Susan D. SpiesExecutive officerOct 2018
Timothy D. FlahertyExecutive officerOct 2018
Michael HoovenExecutive officerNov 2016
Susan SpiesExecutive officerNov 2016
Beckie J. RobertsonDirectorJan 2026
Erik D. FalkDirectorJan 2026
Jim J. CollinsDirectorJan 2026
John J. DeFordDirectorJan 2026
John J. RiceDirectorJan 2026
Michael D. HoovenDirectorJan 2026
Nigel J. SheailDirectorJan 2026
Richard J. D'AugustineDirectorJan 2026
Simone D. SongDirectorJan 2026
Vickie J. CappsDirectorJan 2026
John J RiceDirectorFeb 2022
Karen J RobardsDirectorFeb 2022
Norman R. WeldonDirectorFeb 2022
Richard J D'AugustineDirectorFeb 2022
Simone J SongDirectorFeb 2022
Daniel D. von AllmenDirectorOct 2018
John D. RiceDirectorOct 2018
Mark A. CollarDirectorOct 2018
Norman D. WeldonDirectorOct 2018
Richard D. D'AugustineDirectorOct 2018
Simone A. SongDirectorOct 2018